A target trial emulation found that people with type 2 diabetes who started glucagon-like peptide-1 receptor agonist (GLP-1RA ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is common people with eating disorders, according to a research letter published online June 24 in JAMA ...

The prevalence of GLP-1 receptor agonists for weight management in Great Britain highlights public interest and concerns over ...

Research indicates GLP-1RAs may decrease limb complications in type 2 diabetes with PAD, though more randomized studies are ...

GLP-1 receptor agonist weight loss drugs suppress appetite for food but may also reduce mood and desire for sex in some ...

Online glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescription vendors frequently do not require clinician interaction, according to a research lette ...

Two drugs now generate almost two-thirds of the pharmaceutical giant's revenue.

Medics have issued an urgent warning around an experimental weight loss medication which is currently undergoing clinical ...

Glucagon-like peptide-1 receptor agonists, commonly known as GLP-1s, were first developed to treat type-2 diabetes. Since ...

The eating plan has become a favorite among several high-profile government officials, but it’s about much more than fermented cabbage.

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor Glucagon-like peptide-1 ...

Following the US FDA approval of GLP-1 RA drugs for weight loss, exposures reported to US poison centers increased.